Promising Markers of Preeclampsia : Cardiac Troponin 1 and Brain Natriuretic Peptide in Third Trimester Pregnant Women

Edebiri O.E.; Nwankwo A. A.; Akpe P. E.; Mbanaso E.L.; Ikuenobe V. E.; Omende K.; Ohiwerei W.O

doi:10.70062/greenhealth.v2i2.143

Authors

Edebiri O.E. Ambrose Alli University
Nwankwo A. A. Abia State University
Akpe P. E. University of Benin
Mbanaso E.L. Abia State University
Ikuenobe V. E. Ambrose Alli University
Omende K. Imo State University
Ohiwerei W.O Ohilux Global Research Institute

DOI:

https://doi.org/10.70062/greenhealth.v2i2.143

Keywords:

Brain Natriuretic Peptide (BNP), Cardiac Troponin1 (cTn1), Preeclampsia

Abstract

Cardiac Troponin1 (cTn1) is a protein released into the bloodstream following cardiac damage and Brain Natriuretic Peptide (BNP) is a hormone released by the heart in response to ventricular stretch and pressure overload. This study aims to investigate the predictive role of cTn1 and BNP in preeclamptic pregnant women in the third trimester of pregnancy. Forty (40) consenting pregnant women were recruited from St. Philomina Catholic Hospital, Edo State, Nigeria. Blood samples was spun in a bucket centrifuge at 2500 RPM (rounds per minute) for 10 minutes after which plasma was collected and stored frozen in plain sample bottles and was analyzed for Cardiac Troponin 1(cTn1) and Brain Natriuretic Peptide (BNP) by fluorescence immunoassay. Data obtained from this study were analysed using Graph Pad Prism 9. Results generated were expressed as mean ± SEM and a P-value of ≤ 0.05 were considered statistically significant. The present study showed that there was statistically significant increase in Brain Natriuretic Peptide (BNP) in preeclamptic women compared to normotensive pregnant women, indicating various underlying pathophysiological processes. These findings suggest the potential predictive roles of this cardiac marker in identifying and monitoring preeclampsia.

References

Armaly, Z., Jadaon, J. E., Jabbour, A., & Abassi, Z. A. (2018). Preeclampsia: Novel mechanisms and potential therapeutic approaches. Frontiers in Physiology, 9, 973. https://doi.org/10.3389/fphys.2018.00973

Asmanidar, A., & Emilda, E. (2024). Optimizing maternal healthcare: Holistic strategies for early detection and management of preeclampsia. Science Midwifery, 12(1), 158–167.

Buchan, A., Bennett, R., Coad, A., Barnes, S., Russell, R., & Manuel, A. R. (2015). The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD. Open Heart, 2(1), e000052. https://doi.org/10.1136/openhrt-2014-000052

Cameli, M., Lembo, M., Sciaccaluga, C., Bandera, F., Ciccone, M. M., D’Andrea, A., ... & Galderisi, M. (2020). Identification of cardiac organ damage in arterial hypertension: Insights by echocardiography for a comprehensive assessment. Journal of Hypertension, 38(4), 588–598. https://doi.org/10.1097/HJH.0000000000002338

Carrero, J. J., Andersson Franko, M., Obergfell, A., Gabrielsen, A., & Jernberg, T. (2019). hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: A healthcare‐based study. Journal of the American Heart Association, 8(11), e012638. https://doi.org/10.1161/JAHA.119.012638

Chapelle, J. P. (1999). Cardiac troponin I and troponin T: Recent players in the field of myocardial markers.

Chaulin, A. M. (2022). Biology of cardiac troponins: Emphasis on metabolism. Biology, 11(3), 429. https://doi.org/10.3390/biology11030429

Christenson, E., & Christenson, R. H. (2013). The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome. Annals of Laboratory Medicine, 33(5), 309–319. https://doi.org/10.3343/alm.2013.33.5.309

Conti-Ramsden, F., Gill, C., Seed, P. T., Bramham, K., Chappell, L. C., & McCarthy, F. P. (2019). Markers of maternal cardiac dysfunction in pre-eclampsia and superimposed pre-eclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology, 237, 151–156. https://doi.org/10.1016/j.ejogrb.2019.04.011

Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Seminars in Perinatology, 33(3), 130–137. https://doi.org/10.1053/j.semperi.2009.02.010

Farhat, N. (2019). A study of utility of plasma BNP in patients with chronic obstructive pulmonary disease for detection of cor pulmonale (Doctoral dissertation, Rajiv Gandhi University of Health Sciences).

Gachpazan, M., Mohammadinejad, A., Saeidinia, A., Rahimi, H. R., Ghayour-Mobarhan, M., Vakilian, F., & Rezayi, M. (2021). A review of biosensors for the detection of B-type natriuretic peptide as an important cardiovascular biomarker. Analytical and Bioanalytical Chemistry, 413, 5949–5967. https://doi.org/10.1007/s00216-021-03499-6

Giannitsis, E., & Katus, H. A. (2013). Cardiac troponin level elevations not related to acute coronary syndromes. Nature Reviews Cardiology, 10(11), 623–634. https://doi.org/10.1038/nrcardio.2013.129

Huang, X., Bai, S., & Luo, Y. (2024). Advances in research on biomarkers associated with acute myocardial infarction: A review. Medicine, 103(15), e37793. https://doi.org/10.1097/MD.0000000000037793

Kociol, R. D., Pang, P. S., Gheorghiade, M., Fonarow, G. C., O'Connor, C. M., & Felker, G. M. (2010). Troponin elevation in heart failure: Prevalence, mechanisms, and clinical implications. Journal of the American College of Cardiology, 56(14), 1071–1078. https://doi.org/10.1016/j.jacc.2010.06.016

Lee, W. C., Mosley, T. H., & Knopman, D. S. (2019). Cardiac biomarkers in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 28(1), 101–106. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.019

MacDonald, T. M., Walker, S. P., Hannan, N. J., Tong, S., & Tu'uhevaha, J. (2022). Clinical tools and biomarkers to predict preeclampsia. EBioMedicine, 75, 103800. https://doi.org/10.1016/j.ebiom.2021.103800

Morrow, D. A., & Antman, E. M. (2009). Evaluation of high-sensitivity assays for cardiac troponin. Clinical Chemistry, 55(1), 5–8. https://doi.org/10.1373/clinchem.2008.113795

Morton, A., & Morton, A. (2018). High sensitivity cardiac troponin I levels in preeclampsia. Pregnancy Hypertension, 13, 79–82. https://doi.org/10.1016/j.preghy.2018.05.009

Ravichandran, J., Woon, S. Y., Quek, Y. S., Lim, Y. C., Noor, E. M., Suresh, K., ... & Jaffe, A. S. (2019). High-sensitivity cardiac troponin I levels in normal and hypertensive pregnancy. The American Journal of Medicine, 132(3), 362–366. https://doi.org/10.1016/j.amjmed.2018.09.032

Shah, S. (2020). Hypertensive disorders in pregnancy. In Obstetric and Gynecologic Nephrology: Women’s Health Issues in the Patient With Kidney Disease (pp. 11–23). https://doi.org/10.1007/978-3-030-42142-3_2

Twerenbold, R., Boeddinghaus, J., Nestelberger, T., Wildi, K., Rubini Gimenez, M., Badertscher, P., & Mueller, C. (2017). Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Journal of the American College of Cardiology, 70(8), 996–1012. https://doi.org/10.1016/j.jacc.2017.07.718

Wu, Y., Pan, N., An, Y., Xu, M., Tan, L., & Zhang, L. (2021). Diagnostic and prognostic biomarkers for myocardial infarction. Frontiers in Cardiovascular Medicine, 7, 617277. https://doi.org/10.3389/fcvm.2021.617277